Evidence map›Paper›PMID 26182435›Full record

ArticleBioscience reports2015

Mammalian Bcnt/Cfdp1, a potential epigenetic factor characterized by an acidic stretch in the disordered N-terminal and Ser250 phosphorylation in the conserved C-terminal regions.

Shintaro Iwashita, Takehiro Suzuki, Takeshi Yasuda, Kentaro Nakashima, Taiichi Sakamoto, Toshiyuki Kohno, Ichiro Takahashi, Takayasu Kobayashi, Yoshiko Ohno-Iwashita, Shinobu Imajoh-Ohmi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Cells · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Shintaro IwashitaFaculty of Pharmacy, Iwaki Meisei University, Iwaki 970-8551, Japan siwast@iwakimu.ac.jp.
Takehiro SuzukiCenter for Sustainable Resource Science, RIKEN, Wako 351-0198, Japan.
Takeshi YasudaResearch Center for Radiation Emergency Medicine, National Institute of Radiological Sciences, Chiba 263-8555, Japan.
Kentaro NakashimaInstitute of Neuroscience, Tokushima Bunri University, Sanuki 769-2193, Japan.
Taiichi SakamotoMitsubishi Kagaku Institute of Life Sciences, Machida 194-0031, Japan.
Toshiyuki KohnoMitsubishi Kagaku Institute of Life Sciences, Machida 194-0031, Japan.
Ichiro TakahashiTsukuba Primate Research Center, National Institute of Biomedical Innovation, Tsukuba 305-0843, Japan.
Takayasu Kobayashi*Department of Project Program, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.
Yoshiko Ohno-IwashitaFaculty of Pharmacy, Iwaki Meisei University, Iwaki 970-8551, Japan.
Shinobu Imajoh-Ohmi†Laboratory Center for Proteomics Research, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Si-Young SongInstitute of Neuroscience, Tokushima Bunri University, Sanuki 769-2193, Japan.
Naoshi DohmaeCenter for Sustainable Resource Science, RIKEN, Wako 351-0198, Japan.
Iwaki Meisei University · JPMitsubishi Group (Japan) · JPRIKEN Center for Sustainable Resource Science · JPTokushima Bunri University · JPNational Institute of Biomedical Innovation, Health and Nutrition · JPThe University of Tokyo · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The BCNT (Bucentaur) superfamily is classified by an uncharacteristic conserved sequence of ∼80 amino acids (aa) at the C-terminus, BCNT-C (the conserved C-terminal region of Bcnt/Cfdp1). Whereas the yeast Swc5 and Drosophila Yeti homologues play crucial roles in chromatin remodelling organization, mammalian Bcnt/Cfdp1 (craniofacial developmental protein 1) remains poorly understood. The protein, which lacks cysteine, is largely disordered and comprises an acidic N-terminal region, a lysine/glutamic acid/proline-rich 40 aa sequence and BCNT-C. It shows complex mobility on SDS/PAGE at ∼50 kDa, whereas its calculated molecular mass is ∼33 kDa. To characterize this mobility discrepancy and the effects of post-translational modifications (PTMs), we expressed various deleted His-Bcnt in E. coli and HEK cells and found that an acidic stretch in the N-terminal region is a main cause of the gel shift. Exogenous BCNT/CFDP1 constitutively expressed in HEK clones appears as a doublet at 49 and 47 kDa, slower than the protein expressed in Escherichia coli but faster than the endogenous protein on SDS/PAGE. Among seven in vivo phosphorylation sites, Ser(250), which resides in a region between disordered and ordered regions in BCNT-C, is heavily phosphorylated and detected predominantly in the 49 kDa band. Together with experiments involving treatment with phosphatases and Ser(250) substitutions, the results indicate that the complex behaviour of Bcnt/Cfdp1 on SDS/PAGE is caused mainly by an acidic stretch in the N-terminal region and Ser(250) phosphorylation in BCNT-C. Furthermore, Bcnt/Cfdp1 is acetylated in vitro by CREB-binding protein (CBP) and four lysine residues including Lys(268) in BCNT-C are also acetylated in vivo, revealing a protein regulated at multiple levels.

Indexed as

AcetylationAmino Acid SubstitutionCREB-Binding ProteinEpigenesis, GeneticHEK293 CellsHumansMutation, MissenseNuclear ProteinsPhosphoproteinsPhosphorylationProtein Structure, TertiaryCFDP1 protein, humanCREB-Binding ProteinCREBBP protein, humanNuclear ProteinsPhosphoproteinsBucentaur (BCNT) superfamilydisordered proteinmass spectroscopypost-translational modification (PTM)sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS/PAGE) mobilitythe conserved C-terminal region of Bcnt/Cfdp1 (BCNT-C) domain

Identifiers

PMID26182435
PMCPMC4613681
OpenAlexW1953899776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.